Company Filing History:
Years Active: 2000
Title: The Innovations of Patrice Preville
Introduction
Patrice Preville is a notable inventor based in Saint-Charles Borromee, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anticoagulant therapies. His work focuses on innovative solutions to combat thrombotic disorders, which are critical in medical treatments.
Latest Patents
Patrice Preville holds a patent for "Low molecular weight bicyclic thrombin inhibitors." This invention pertains to the discovery of heterocyclic competitive inhibitors of the enzyme thrombin, their preparation, and pharmaceutical compositions. The patent outlines the use of these compounds and compositions as anticoagulants in vitro and as agents for the treatment and prophylaxis of thrombotic disorders such as venous thrombosis, pulmonary embolism, and arterial thrombosis. These conditions can lead to acute ischemic events, including myocardial infarction and cerebral infarction. Furthermore, the compounds have therapeutic utility for preventing and treating coagulopathies associated with coronary bypass operations and restenotic events following transluminal angioplasty. He has 1 patent to his name.
Career Highlights
Patrice Preville has established himself as a key figure in the pharmaceutical industry. His innovative approach to thrombin inhibitors has positioned him as a valuable contributor to advancements in medical treatments. His work is essential in addressing critical health issues related to blood coagulation and thrombotic events.
Collaborations
Throughout his career, Patrice has collaborated with esteemed colleagues, including John DiMaio and M Arshad Siddiqui. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking pharmaceutical solutions.
Conclusion
Patrice Preville's contributions to the field of pharmaceuticals, particularly through his patent on thrombin inhibitors, highlight his innovative spirit and dedication to improving medical treatments. His work continues to have a significant impact on the management of thrombotic disorders.